What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Medulloblastoma, Cancer research, Bioinformatics, Genetics and Gene expression profiling.
His study in Medulloblastoma is interdisciplinary in nature, drawing from both Cancer, Clinical trial and Genomics.
His research integrates issues of Immunology, Sonic hedgehog, microRNA, Regulation of gene expression and Gene silencing in his study of Cancer research.
His Bioinformatics research is multidisciplinary, relying on both Wnt signaling pathway and Gene.
The various areas that Michael D. Taylor examines in his Gene expression profiling study include Consensus conference, Disease, Ependymoma, Computational biology and Molecular classification.
His Pathology study deals with DNA methylation intersecting with Methylation.
His most cited work include:
- International network of cancer genome projects (1611 citations)
- Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. (1142 citations)
- Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. (1139 citations)
What are the main themes of his work throughout his whole career to date?
Michael D. Taylor mainly investigates Medulloblastoma, Cancer research, Internal medicine, Pathology and Oncology.
He combines subjects such as Cancer, Metastasis, Wnt signaling pathway, Bioinformatics and Sonic hedgehog with his study of Medulloblastoma.
His research in Bioinformatics intersects with topics in Gene expression profiling, Disease and Genomics.
Michael D. Taylor works mostly in the field of Cancer research, limiting it down to concerns involving DNA methylation and, occasionally, Methylation.
His Pathology study is mostly concerned with Ependymoma and Immunohistochemistry.
His Gene study improves the overall literature in Genetics.
He most often published in these fields:
- Medulloblastoma (52.32%)
- Cancer research (36.85%)
- Internal medicine (16.17%)
What were the highlights of his more recent work (between 2018-2021)?
- Medulloblastoma (52.32%)
- Cancer research (36.85%)
- Internal medicine (16.17%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Medulloblastoma, Cancer research, Internal medicine, Oncology and Ependymoma.
His Medulloblastoma study incorporates themes from Wnt signaling pathway, Sonic hedgehog, Radiation therapy, Radiology and Cell biology.
The study incorporates disciplines such as Chromatin and Gene silencing in addition to Cell biology.
Michael D. Taylor interconnects Cell, Stem cell, Pediatric cancer, Epigenetics and Immunotherapy in the investigation of issues within Cancer research.
His work investigates the relationship between Epigenetics and topics such as DNA methylation that intersect with problems in Methylation.
As a part of the same scientific family, Michael D. Taylor mostly works in the field of Oncology, focusing on BRAF V600E and, on occasion, Mutation.
Between 2018 and 2021, his most popular works were:
- Challenges to curing primary brain tumours (159 citations)
- Childhood cerebellar tumours mirror conserved fetal transcriptional programs (122 citations)
- Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data (100 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Michael D. Taylor mostly deals with Medulloblastoma, Cancer research, Internal medicine, Oncology and Sonic hedgehog.
His study of Recurrent Medulloblastoma is a part of Medulloblastoma.
His Cancer research research integrates issues from Somatic cell, Carcinogenesis, Progenitor cell, Stem cell and Immunotherapy.
His studies deal with areas such as Neurooncology and Cardiology as well as Internal medicine.
As part of one scientific family, Michael D. Taylor deals mainly with the area of Oncology, narrowing it down to issues related to the Primary tumor, and often Etiology, Medical diagnosis and Mesothelioma.
His Clinical trial research incorporates elements of Basic science, Disease and Genomics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
